Major Investor Registers 375,000 Shares for Resale, Potentially Diluting Existing Shareholders by 8.9%

summarizeSummary

A major investor, The Patel Family, LLP, has registered 375,000 shares for resale, representing a potential 8.9% dilution, with the company receiving no proceeds from these sales.

check_boxKey Events · Financing and Capital Events · TVGN

• Major Investor Registers Shares for Resale

  The Patel Family, LLP, a significant investor and related party, has registered up to 375,000 shares of common stock for resale. This filing makes these shares available for sale on the open market.

• Significant Potential Dilution

  The 375,000 shares represent approximately 8.9% of the company's 4,219,343 outstanding common shares as of June 11, 2026, creating a substantial potential for dilution.

• No Proceeds to Company

  Tevogen Bio Holdings Inc. will not receive any proceeds from the sale of these shares by the selling stockholder, only a negligible $37.50 from warrant exercise.

• Follows Recent PIPE Financing

  The shares are issuable upon exercise of pre-funded warrants that were part of a $3.0 million private investment in public equity (PIPE) financing from The Patel Family, LLP in May 2026.

auto_awesomeAnalysis · TVGN · Life Sciences

This prospectus supplement finalizes the registration for resale of 375,000 shares by The Patel Family, LLP, a major investor. These shares, originating from pre-funded warrants issued in May 2026, represent a potential dilution of approximately 8.9% of the company's outstanding common stock. Critically, Tevogen Bio will not receive any proceeds from these sales, which is a negative signal given the company's precarious cash position and ongoing Nasdaq delisting concerns related to its market value. The availability of these shares for sale creates an overhang on the stock price.